The shingles vaccine has long been recommended to prevent a painful viral infection—but emerging research suggests it may do something far more powerful: reduce the risk of dementia by up to ~20–30% and potentially slow disease progression.
This is one of the most exciting developments in preventive medicine, linking viral infections, inflammation, and brain health.
What Is Shingles?
- Shingles is caused by the varicella-zoster virus, the same virus that causes chickenpox.
- After chickenpox, the virus remains dormant in nerve tissue
- It can reactivate later in life as shingles
Symptoms include:
- Painful rash
- Burning or nerve pain
- Fatigue, fever, headache
- The burning pain can become permanent
Shingles risk increases significantly with age and immune decline.
What Is the Shingles Vaccine Called?
The current vaccine used in the U.S. is: Shingrix (recombinant zoster vaccine).
- >90% effective at preventing shingles
- Given as a 2-dose series
- Doses are spaced 2–6 months apart
Who Should Get the Shingles Vaccine?
Recommended groups:
- All adults age 50 and older
- Adults 19+ with weakened immune systems
Birth-year insight:
- Most adults born before ~1980 have had chickenpox and carry the virus → at risk for shingles
Can You Get the Vaccine If You’ve Already Had Shingles?
Yes — and you should. Shingles can occur more than once.
Vaccination reduces risk of:
- Recurrence
- Long-term nerve pain
- Complications like stroke
What If You Got One Dose But Not the Second?
—One dose provides partial, short-term protection
Two doses are required for:
- Full immunity
- Long-term protection (>90% efficacy)
Where Can You Get the Vaccine?
Widely available at:
Pharmacies (CVS, Walgreens, etc.)
The Breakthrough: Shingles Vaccine and Dementia Risk
Recent large-scale studies have revealed a striking association. Key findings include:
- ~20% lower risk of developing dementia over 7 years
- Up to 30% reduction in dementia-related mortality in some cohorts
- Reduced likelihood of:
Mild cognitive impairment
Alzheimer’s disease
Potential slowing of disease progression in those already diagnosed
A major Nature (2025) study used a “natural experiment” in Wales, comparing individuals born just weeks apart—one group eligible for vaccination, the other not—providing unusually strong real-world evidence.
Why Would a Vaccine Affect Brain Health?
Researchers believe several mechanisms may explain this:
1. Reduced Neuroinflammation
- Shingles triggers inflammation in nerve tissue
- Chronic inflammation is strongly linked to dementia
2. Prevention of Viral Reactivation
- The virus can affect the brain and nervous system
- Preventing reactivation protects neurons
3. Immune System Modulation
- Vaccination may enhance immune surveillance in the brain
4. Reduced Stroke Risk
- Shingles increases stroke risk
- Stroke contributes to vascular dementia
How Strong Is the Evidence?
- Large population studies (hundreds of thousands of patients)
- Natural experiment design approximating randomized trials
- Consistent findings across UK, Australia, and United States
- Some analyses suggest ~31% lower dementia risk overall with shingles vaccination
Additional Benefits of the Shingles Vaccine
- Prevents shingles (>90% effective)
- Reduces risk of postherpetic neuralgia (chronic nerve pain)
- May reduce:
Stroke risk
Systemic inflammation
Hospitalization in older adults
Bottom Line
The shingles vaccine is no longer just about preventing a painful rash.It is now increasingly viewed as a brain-protective intervention, with growing evidence showing:
- Reduced dementia risk
- Slower cognitive decline
- Potential impact on long-term neurologic health
For adults over 50, this is one of the simplest, most powerful preventive tools available today.
References
1. Geldsetzer P, et al. Association of shingles vaccination with reduced dementia incidence. Nature. 2025.
2. Geldsetzer P, et al. Shingles vaccination and dementia progression. Cell. 2025.
3. Shmerling RH. Can a routine vaccine prevent dementia? Harvard Health Publishing. 2025.
4. Jacobson A. Shingles vaccine and dementia risk reduction. GoodRx Health. 2025.
5. University Hospitals Neurology Institute. Shingles vaccine and Alzheimer’s disease risk. 2025.
6. Epic Research. Shingles vaccination correlated with reduced likelihood of dementia and Alzheimer’s. 2025.
7. ScienceAlert. Shingles vaccine reduces dementia mortality risk by ~30%. 2025.